Swiggy's quick commerce division, Swiggy Instamart, has reportedly entered into a partnership with PharmEasy to deliver prescription medicines within 10 minutes, according to a report by Moneycontrol.
Although Swiggy has yet to make an official announcement, Instamart has already been delivering over-the-counter (OTC) medications, including pain relief sprays, as part of its existing service.
The latest partnership marks Swiggy’s deeper expansion into the e-pharmacy market, aiming to reach a broader user base in need of quick access to medications.
The report said the service is currently being piloted in Bengaluru, where Swiggy will deliver essential medications such as pain relievers, fever treatments, and other prescription-required drugs.
Leveraging PharmEasy’s infrastructure
A significant aspect of this partnership is the unique "shop-in-shop" setup, where PharmEasy stores operate within Swiggy's dark stores—localized storage facilities for quick delivery.
This setup would enable Swiggy to quickly fulfill medicine orders, especially those requiring regulatory compliance, such as prescription medications. The pilot in Bengaluru will inform further expansions, potentially bringing the service to more cities if successful.
Swiggy Instamart competes with Zomato-owned Blinkit, Zepto, and Bigbasket.
Swiggy IPO
Zomato rival Swiggy is likely to launch its mega IPO for public subscription between November 6 and November 8, 2024, Moneycontrol reported. The report said that the Bengaluru-based company is targeting an IPO valuation of around$11.3 billion.
The report further said that the primary component of the issue has been upsized to around Rs 4,500 crore, and the offer-for-sale component has also been tweaked depending on investor participation.